Clinical Trial of H2-BP Electronic Sphygmomanometer
Launched by GANGNAM SEVERANCE HOSPITAL · Jun 30, 2024
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Outpatients and inpatients aged 19 years or older showing hypotension, normal blood pressure, prehypertension, and hypertension
- • Individuals who meet the criteria for wrist circumference, age, gender, and upper arm circumference as specified in the target number of participants.
- • Those who have listened to a detailed explanation of the clinical trial, fully understand it, voluntarily decide to participate, and provide written consent to comply with precautions.
- Exclusion Criteria:
- • Patients who do not consent to participate in the study.
- • Individuals who may not maintain stable blood pressure for approximately 30 minutes due to conditions resembling hypovolemia or similar conditions.
- • Those who may not maintain stable blood pressure for approximately 30 minutes due to short-acting vasodilators or similar medications.
- • Individuals with arrhythmia.
- • Those who have eaten within 30 minutes before blood pressure measurement.
- • Individuals who have consumed caffeine-containing beverages within 1 hour or smoked within 15 minutes before measurement.
- • Participants who have exercised immediately before blood pressure measurement.
- • Other patients deemed unsuitable for the study at the discretion of the researchers.
About Gangnam Severance Hospital
Gangnam Severance Hospital is a renowned medical institution located in Seoul, South Korea, dedicated to advancing healthcare through innovative research and clinical excellence. As a leading clinical trial sponsor, the hospital is committed to conducting cutting-edge research that enhances patient care and contributes to medical knowledge across various specialties. With a state-of-the-art facility and a multidisciplinary team of experienced researchers and healthcare professionals, Gangnam Severance Hospital prioritizes patient safety and ethical standards while striving to develop new treatments and therapies that address unmet medical needs. Through collaboration with academic institutions and industry partners, the hospital plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported